University of Oxford collaborators from the Pandemic Sciences Institute and the Department of Statistics will keep contributing actively to the new iteration of the Health Protection Research Unit in Emerging and Zoonotic Infections.
The Pandemic Sciences Institute welcomed the Moh Family Foundation to Oxford to share latest research updates and celebrate the Foundation\u2019s generous support.
A new study in BMJ Global Health reveals the key Long Covid characteristics affecting populations worldwide, including fatigue, shortness of breath and having trouble thinking clearly. 6-12 months after hospital discharge, 70% of study participants were affected by Long Covid in high-income countries, and 42% in low and middle-income countries.
Leading infectious disease epidemiologist Professor Adam Kucharski presented on opportunities to generate key insights into pandemic pathogens while implementing outbreak control measures, using insights from COVID-19, as part of a new series of pandemic sciences seminars.
A brand-new season of The Oxford Colloquy \u2013 a podcast series of conversations with leading experts in science and healthcare \u2013 is launched this week by Oxford Vaccine Group.
PSI Investigator Professor Sassy Molyneux has received a prestigious five-year NIHR Global Health Research Professorship. This award, granted to only five distinguished scientists annually, will support Professor Molyneux\u2019s research on protecting frontline staff from moral distress.
The International Pandemic Sciences Conference 2024, held on 1 and 2 July in Oxford and online, has concluded with remarkable success, drawing over 700 delegates from more than 60 countries.
Professor Sir Peter Horby responds to the UK Covid-19 Inquiry's Module 1 report published today, which focuses on the UK's pandemic resilience and preparedness.
Launch of UK trial is major milestone in developing a vaccine against Marburg virus \u2013 a highly virulent disease that is fatal in up to 88% of cases.
Researchers analysing data from mobile phone apps used during the COVID-19 pandemic found that digital contact tracing can help public health bodies to better monitor and analyse evolving epidemics.
PSI scientists are launching a new computer simulations project to model vaccine clinical trial designs and strengthen global response to pandemic threats.
Professor Teresa Lambe OBE, Calleva Head of Immunology at the Oxford Vaccine Group, and Principal Investigator at the Pandemic Sciences Institute, has been elected a Fellow of the Academy of Medical Sciences, one of the most prestigious awards in the field.
Professor Sir Peter Horby has been elected as a Fellow of the Royal Society, joining a cohort of the world\u2019s most eminent scientists, engineers and technologists who have made substantial contributions to the advancement of science.
![\"\"](\"https://www.psi.ox.ac.uk/news-and-opinion/reconstructing-a-lifetime-of-flu-infections-to-understand-long-term-trends/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n